Jim Simons Takeda Pharmaceutical CO LTD Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 3,218,800 shares of TAK stock, worth $42.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,218,800

Previous 2,954,800 8.93%

Holding current value

$42.4 Million

Previous $38.2 Million 19.63%

% of portfolio

0.07%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$13.0 - $15.08 $3.43 Million - $3.98 Million	264,000 Added 8.93%	3,218,800 $45.7 Million
Q2 2024 Aug 09, 2024	SELL	$12.6 - $13.67 $2.06 Million - $2.23 Million	-163,400 Reduced 5.24%	2,954,800 $38.2 Million
Q1 2024 May 13, 2024	SELL	$13.89 - $15.04 $2.91 Million - $3.15 Million	-209,200 Reduced 6.29%	3,118,200 $43.3 Million
Q4 2023 Feb 13, 2024	BUY	$13.36 - $15.43 $1.29 Million - $1.49 Million	96,500 Added 2.99%	3,327,400 $47.5 Million
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $6.3 Million - $6.84 Million	-419,100 Reduced 11.48%	3,230,900 $50 Million
Q2 2023 Aug 11, 2023	BUY	$15.57 - $17.11 $10.5 Million - $11.6 Million	676,600 Added 22.76%	3,650,000 $57.3 Million
Q1 2023 May 12, 2023	BUY	$15.28 - $16.48 $1.67 Million - $1.8 Million	109,000 Added 3.81%	2,973,400 $49 Million
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $190,026 - $238,986	15,300 Added 0.54%	2,864,400 $44.7 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $266,240 - $595,920	20,800 Added 0.74%	2,849,100 $37 Million
Q2 2022 Aug 12, 2022	BUY	$13.12 - $15.03 $11 Million - $12.6 Million	835,100 Added 41.9%	2,828,300 $39.7 Million
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $3.72 Million - $4.21 Million	274,400 Added 15.96%	1,993,200 $28.5 Million
Q4 2021 Feb 11, 2022	SELL	$13.17 - $16.4 $5.77 Million - $7.18 Million	-438,100 Reduced 20.31%	1,718,800 $23.4 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $2.28 Million - $2.42 Million	-140,100 Reduced 6.1%	2,156,900 $35.3 Million
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $18.8 Million - $21.2 Million	-1,137,600 Reduced 33.12%	2,297,000 $38.7 Million
Q1 2021 May 13, 2021	SELL	$16.71 - $19.9 $35.8 Million - $42.7 Million	-2,144,100 Reduced 38.43%	3,434,600 $62.7 Million
Q4 2020 Feb 10, 2021	SELL	$15.39 - $18.97 $2.43 Million - $3 Million	-158,007 Reduced 2.75%	5,578,700 $102 Million
Q3 2020 Nov 13, 2020	BUY	$17.1 - $19.19 $2.21 Million - $2.48 Million	129,007 Added 2.3%	5,736,707 $102 Million
Q2 2020 Aug 13, 2020	BUY	$14.59 - $19.5 $26.9 Million - $36 Million	1,844,300 Added 49.01%	5,607,700 $101 Million
Q1 2020 May 14, 2020	BUY	$13.02 - $20.31 $22.9 Million - $35.6 Million	1,755,211 Added 87.4%	3,763,400 $57.1 Million
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $5.13 Million - $6.33 Million	303,789 Added 17.82%	2,008,189 $39.6 Million
Q3 2019 Nov 13, 2019	BUY	$16.15 - $17.99 $15 Million - $16.7 Million	930,600 Added 120.26%	1,704,400 $29.3 Million
Q2 2019 Aug 12, 2019	BUY	$16.58 - $20.49 $12.8 Million - $15.9 Million	773,800 New	773,800 $13.7 Million

Others Institutions Holding TAK

# of Institutions

338

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account